Pfizer

Data indicates that risks associated with OXBRYTA include higher incidence of vaso-occlusive crises and fatal events

Pfizer plans clinical trials for a once-daily weight-loss pill, danuglipron, after scrapping twice-daily version

Moderna alleges Pfizer/BioNTech copied mRNA technology that it had patented between 2010 and 2016

Britain is scrambling to build its defences amid a record surge in Covid-19 cases in the winter season

Getting vaccinated is the best gift you can give to your loved ones this holiday season, says US chargé d’affaires

2 doses of vaccine reduce hospitalisations due to Omicron by 70%, says research by South African health insurance

The drugmaker applied for emergency authorisation of the drug, branded as Paxlovid, this week

Planned analysis of 1,219 patients looked at hospitalisations or deaths among people diagnosed with coronavirus

The drugmaker has been racing to develop an easy-to-administer antiviral pill for Covid-19

Forum says NADRA’s Form B will be required for registration purpose

Doses to arrive in time to assist Pakistani government in mitigating the fourth Covid-19 wave, says US embassy

64,000 doses of Pfizer vaccine reach Islamabad; 16-year-old students to get Moderna shots

Saudi Arabia has so far approved Pfizer, AstraZeneca, Johnson and Johnson, and Moderna vaccines.

Researchers trying to determine just what level of Covid-19 antibodies vaccine must produce to provide protection

Protesters gather outside F-9 vaccination centre

With deliveries of the first 200m doses to begin in August 2021 as US aims to distribute to 92 lower-income countries

Interior minister says 'does not see any opposition' against PM Imran; terms rivals useless, ineffective

Minister inaugurates vaccination centre at Centaurus Mall

Pfizer/BioNTech, mRNA vaccine protects not only against the original virus strain but also against worrisome variants

Marking the first time the drugmaker has delivered abroad from US facilities after a Trump-era restriction

“We have more than enough Pfizer and Moderna vaccines to cover all of the remaining eight and a half million people,”

First volunteers in early-stage trial were given their first injections on Wednesday, says Pfizer spokesperson

Drugmaker says the antiviral candidate showed potent activity against SARS-CoV-2 in lab studies

Ultra-cold freezers have capacity to maintain temperature at -70° C

India's drug regulator says its experts did not recommend vaccine because of side effects reported abroad

Initial data on immune responses expected to be generated around June

Pfizer says it can produce up to 1.3 billion doses around the world this year

Doctors are still studying whether doctor’s seizures and decreased muscle strength are related to Covid-19 vaccine

Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them

UN health agency says it will work with regional partners to tell national health authorities about two-dose shot

AstraZeneca vaccine’s efficacy in preventing infections was 70.4%, compared with Pfizer/BioNTech's efficacy of 95%

Govt hopes to give the first dose of Oxford or the Pfizer vaccine to 2 million people over the next two weeks

Moderna expects immunity from its vaccine to protect against the variants

Use of such vaccines permitted as long as there were no alternatives, Vatican tells Roman Catholics

Scheme’s promoters say programme is struggling from lack of funds, supply risks and complex contractual arrangements

In the first week of roll-out of the shot developed by Pfizer and BioNTech says minister

First batch of shots is expected to aim health care workers and residents and staff of long-term care facilities

Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients

Officials from around the world keen to get information about the two reported cases of anaphylaxis

Pfizer is also studying its vaccine candidate in participants as young as 12

NHS official says advice changed after two NHS workers reported anaphylactoid reactions after receivig vaccine

It will become clear after several months that how long does the vaccination will protect someone from coronavirus

People aged 80 and over, care home workers, staff in the National Health Service (NHS) will be prioritised

Company says it anticipates producing 50 million doses of its Covid-19 vaccine this year

The first immunisations using the BioNTech and Pfizer vaccine could take place from December 7

Pfizer and BioNTech said that final data showed their shot was 95% effective against Covid-19

Most Covid-19 survivors are likely to have lasting protection against severe the virus if they become reinfected

The vaccine’s efficacy rate, the highest of any candidate in late-stage clinical trials so far

The vaccine needs to be stored at minus 70 degrees Celsius (-94 F) or below - equivalent to an Antarctic winter

Decision bars other companies from making cheaper copies of vaccine, allows Pfizer to exclusively sell it until 2026